Teva's Turnarond: Is It Ever Or Never?The generic drug giant’s U.S.-listed share price is getting hammered after the company revealed that worsening price pressures on U.S. drugs have significantly dimmed its outlook for the coming year. What does this mean for efforts underway to fix the company's failing fortunes?

[Collection]The generic drug giant’s U.S.-listed share price is getting hammered after the company revealed that worsening price pressures on U.S. drugs have significantly dimmed its outlook for the coming year. What does this mean for efforts underway to fix the company's failing fortunes?https://www.forbes.com/sites/johannabennett/2018/02/08/tevas-turnarond-is-it-ever-or-never/